Biotheranostics, Syapse collaborate on precision medicine

Tuesday, September 27, 2016

Biotheranostics, a pioneer in molecular diagnostics for cancer, and Syapse, a precision medicine software provider, plans to integrate data from Biotheranostics’ CancerTYPE ID and Breast Cancer IndexSM genomic tests into the Syapse Precision Medicine Platform. The software-based service is part of Syapse’s Global Partner Program that aims to leverage strong collaborators toward an integrative approach to precision medicine.

[Read More]